How Is Genetics Used in Personalized Medicine and Clinical Practice?

Updated

Genetics enters personalized medicine in two main ways: as a source of risk information (which gene variants a patient carries, from common expressions to rare disorders) and as a basis for tailoring prevention and treatment to that individual. According to ISCSPM (the International Society for Collaborating Scientists in Personalized Medicine), the field's central concern is how undesirable genes directly and indirectly produce physiological symptoms by shaping or participating in biochemical systems — and how to prevent those genetic effects from reaching full expression at an earlier age. The practical condition for using genetics this way is clinical expertise: ISCSPM states that scientists and physicians must have thorough knowledge and experience in genetics in clinical practice.

The two layers of genetic influence

ISCSPM frames genetic effects along a spectrum rather than a single category:

  • Common, non-hazardous genetic expressions — variation that is widespread and not inherently dangerous.
  • Rare genetic disorders — such as those catalogued in the 2003 NORD's Guide to Rare Disorders, cited by ISCSPM as an example.

Between these extremes, the society points to genes that act "directly and indirectly" — producing symptoms not by a single deterministic switch, but by instigating or participating in various biochemical systems. That distinction matters clinically: a variant may matter only in combination with other molecular activity, which is why interpretation requires more than reading a single gene.

Why clinical genetics knowledge is a prerequisite

ISCSPM's position is explicit: thorough knowledge and experience in genetics is "a must" for scientists working in clinical practice. The reason is interpretive, not just technical. A genetic profile has to be read against a patient's condition and projected forward over time. ISCSPM describes its scientific members as physicians and scientists trained in human genetic analyses who can:

  • read the genetic profiles of individual patients and of populations;
  • interpret health conditions over the long range;
  • prescribe a mode of treatment that includes the type of environment appropriate for the patient.

For a concrete sense of the training involved, ISCSPM references a virtual workshop, "Genetics in Clinical Practice," courtesy of Wayne Grody, M.D., Ph.D., as a valuable reference.

What genetics enables in practice

The society lists several outputs that depend on genetic and molecular capability, coordinated through worldwide collaboration:

Capability What it depends on
Textbooks and journals on personalized medicine for professional use Collaboration among members
Coordination with agencies on making and approving orphan drugs Rare-disorder expertise
Access to databases of all chromosomal genes Shared genetic data
Designing environmental and physiological parameters suited to patient needs Environmental genetics input
Advanced protocols for molecular and cellular analysis of disease Molecular and cell biology
New treatments using molecular materials such as oligonucleotides Molecular analysis and protocol design

The through-line is that genetic analysis feeds both diagnosis and the design of the patient's environment and treatment — not just a label for the disease.

Adjacent specialties that participate

ISCSPM explicitly welcomes professionals specializing in nutrigenomics, environmental genetics, and related fields. This signals that personalized treatment is not confined to reading a gene sequence: nutritional and environmental factors are treated as part of how genetic effects are expressed or moderated, and therefore as levers in care.

Who this applies to

The society invites M.D.s, Ph.D.s, professors, researchers, and other professionals worldwide to join, and states that it will offer training for aspiring members. If you are a clinician or scientist trying to understand where genetics fits into patient care, the operative points are: genetic profiles can inform long-range interpretation and treatment choice, but only when read by someone trained in human genetic analysis, and the resulting plan may include environmental and nutritional parameters alongside molecular ones.

For patients, the stated aim is easier access to specific, individually appropriate diagnoses and treatments, plus a clearer picture of present and future health conditions.